News
-
-
COMMUNIQUÉ DE PRESSE
The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation
CMS revises National Coverage Determination for allogeneic HSCT in MDS patients following requests from ASH, ASTCT, NMDP, and CIBMTR. Updated ruling expands Medicare coverage for life-saving treatment -
-
-
-
COMMUNIQUÉ DE PRESSE
ASTCT to Present Distinguished Honors at the 2024 Tandem Meetings
ASTCT presents top awards to leaders in transplantation and cellular therapy at the Tandem Meetings in San Antonio. Dr. Gerard Socie receives the 2024 Lifetime Achievement Award for his research on Graft-versus-host disease -
-
-
COMMUNIQUÉ DE PRESSE
ASTCT Supports the FDA’s Accelerated Approval of AMTAGVI for Treatment of Metastatic Melanoma
The American Society for Transplantation and Cellular Therapy supports FDA's accelerated approval of lifileucel for unresectable or metastatic melanoma, offering new hope in solid tumor cancer treatment -
COMMUNIQUÉ DE PRESSE
American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award
The American Society for Transplantation and Cellular Therapy will honor Robin Roberts with the 2024 Public Service Award for her advocacy in raising awareness for bone stem cell transplant and advancing breakthroughs in HCT and cell therapy
